Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Masashi Fujii, MD
CONTACT
Sachika Koyama, Ms
CONTACT
Lead
Japan Clinical Cancer Research Organization
This study is to verify the advantage of FOLFOXIRI plus cetuximab over FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer patients with RAS wild-type tumors. In this study the investigators employed deepness of response as a primary endpoint.
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted